Top Markets
Coin of the day
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Rangering i aksjer #30415
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Aksjekurs
$0.91993619
Markedsverdi
$16.95M
Endring (1 dag)
-2.76%
Endring (1 år)
-63.00%
Land
JP
Handel Perseus Proteomics Inc. (4882)

Kategori

Historikk for aksjesplitt for Perseus Proteomics Inc. (4882)
Aksjen Perseus Proteomics Inc. (symbol: 4882) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 19, 2026.
Én 4882-aksje kjøpt før Aug 19, 2026 tilsvarer i dag 0 4882-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
4 x15
US
7 x432
US
0 -
US
2 x10000
CH
7 x226
US